Tri-Pac

Executive Summary

Tri-Pac, a privately held contract development and manufacturing organization (CDMO) based in Minneapolis, has been providing specialized services in drug delivery and medical device filling since 1990. The company offers a comprehensive suite of capabilities including contract development, manufacturing, and filling for various dosage forms such as aerosols, tubes, liquids, suppositories, jars, and foams. With a focus on OTC and medical device products, Tri-Pac positions itself as a versatile partner for pharmaceutical and healthcare companies seeking reliable GMP-compliant manufacturing solutions. Despite operating in a competitive CDMO landscape, Tri-Pac's long-standing presence and broad service portfolio suggest a steady client base and potential for growth as outsourcing trends continue in the pharmaceutical industry. However, the lack of publicly disclosed financials, funding history, or recent press releases limits visibility into its current performance and strategic direction. The company's ability to maintain its market position and capture new business will depend on its operational efficiency, regulatory compliance, and ability to adapt to evolving client needs in drug delivery and medical device manufacturing.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Win with Pharmaceutical Partner60% success
• Q4 2026Capacity Expansion or Facility Upgrade Announcement40% success
• TBDStrategic Partnership or Acquisition to Broaden Service Offerings30% success